Sign In
Buy NRIX
$18.65
+1.10 (+6.27%)
At Close: Jun 22, 2026
Nurix Therapeutics Earnings Calls
May 30, 2026
(Upcoming)
| Release date | Jul 09, 2026 |
| EPS estimate | -$0.730 |
| EPS actual | - |
| Revenue estimate | 15.95M |
| Revenue actual | - |
| Expected change | +/- 9.08% |
Feb 28, 2026
-$0.790 (-3.95%)
| Release date | Apr 08, 2026 |
| EPS estimate | -$0.760 |
| EPS actual | -$0.790 |
| EPS Surprise | -3.95% |
| Revenue estimate | 14.253M |
| Revenue actual | 6.252M |
| Revenue Surprise | -56.13% |
Nov 30, 2025
-$0.82 (2.38%)
| Release date | Jan 28, 2026 |
| EPS estimate | -$0.84 |
| EPS actual | -$0.82 |
| EPS Surprise | 2.38% |
| Revenue estimate | 13.399M |
| Revenue actual | 13.577M |
| Revenue Surprise | 1.33% |
Aug 31, 2025
-$1.03 (-22.62%)
| Release date | Oct 09, 2025 |
| EPS estimate | -$0.84 |
| EPS actual | -$1.03 |
| EPS Surprise | -22.62% |
| Revenue estimate | 12.26M |
| Revenue actual | 7.894M |
| Revenue Surprise | -35.61% |
Last 4 Quarters for Nurix Therapeutics
Below you can see how NRIX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Aug 31, 2025
Missed
| Release date | Oct 09, 2025 |
| Price on release | $10.86 |
| EPS estimate | -$0.84 |
| EPS actual | -$1.03 |
| EPS surprise | -22.62% |
| Date | Price |
|---|---|
| Oct 03, 2025 | $9.38 |
| Oct 06, 2025 | $9.95 |
| Oct 07, 2025 | $9.83 |
| Oct 08, 2025 | $9.98 |
| Oct 09, 2025 | $10.86 |
| Oct 10, 2025 | $9.76 |
| Oct 13, 2025 | $9.72 |
| Oct 14, 2025 | $9.18 |
| Oct 15, 2025 | $10.35 |
| 4 days before | 15.78% |
| 4 days after | -4.70% |
| On release day | -10.13% |
| Change in period | 10.34% |
Nov 30, 2025
Beat
| Release date | Jan 28, 2026 |
| Price on release | $17.87 |
| EPS estimate | -$0.84 |
| EPS actual | -$0.82 |
| EPS surprise | 2.38% |
| Date | Price |
|---|---|
| Jan 22, 2026 | $19.39 |
| Jan 23, 2026 | $18.56 |
| Jan 26, 2026 | $18.75 |
| Jan 27, 2026 | $19.41 |
| Jan 28, 2026 | $17.87 |
| Jan 29, 2026 | $17.59 |
| Jan 30, 2026 | $16.52 |
| Feb 02, 2026 | $17.09 |
| Feb 03, 2026 | $16.79 |
| 4 days before | -7.84% |
| 4 days after | -6.04% |
| On release day | -1.57% |
| Change in period | -13.41% |
Feb 28, 2026
Missed
| Release date | Apr 08, 2026 |
| Price on release | $15.60 |
| EPS estimate | -$0.760 |
| EPS actual | -$0.790 |
| EPS surprise | -3.95% |
| Date | Price |
|---|---|
| Apr 01, 2026 | $15.48 |
| Apr 02, 2026 | $15.51 |
| Apr 06, 2026 | $15.79 |
| Apr 07, 2026 | $16.35 |
| Apr 08, 2026 | $15.60 |
| Apr 09, 2026 | $16.24 |
| Apr 10, 2026 | $16.03 |
| Apr 13, 2026 | $15.91 |
| Apr 14, 2026 | $16.30 |
| 4 days before | 0.775% |
| 4 days after | 4.49% |
| On release day | 4.10% |
| Change in period | 5.30% |
May 30, 2026
(Upcoming)
| Release date | Jul 09, 2026 |
| Price on release | - |
| EPS estimate | -$0.730 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $17.04 |
| Jun 16, 2026 | $17.07 |
| Jun 17, 2026 | $17.12 |
| Jun 18, 2026 | $17.55 |
| Jun 22, 2026 | $18.65 |
Nurix Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for NRIX?
Nurix Therapeutics, Inc. (NRIX) has scheduled its earnings report for Jul 09, 2026 before the markets open.
What is the NRIX price-to-earnings (P/E) ratio?
NRIX P/E ratio as of Jun 22, 2026 (TTM) is -6.54.
What is the NRIX EPS forecast?
The forecasted EPS (Earnings Per Share) for Nurix Therapeutics, Inc. (NRIX) for the first fiscal quarter 2026 is -$0.730.
What are Nurix Therapeutics, Inc.'s retained earnings?
On its balance sheet, Nurix Therapeutics, Inc. reported retained earnings of $6.25 million for the latest quarter ending Feb 28, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
